The Ministry of Health, Labor and Welfare (MHLW) appears to be ready to begin post-launch drug price adjustments based on cost-effectiveness assessments (CEAs) for the first time since the system was introduced in April 2019. As price tweaks will be…
To read the full story
COLUMN
- Do You Attract or Repel Winning Candidates?
April 16, 2021
- The Future of Customer Engagement in Japan’s Life Science Industry: One Year Post-COVID
March 19, 2021
- What Personal Biases Influence Your Hires?
February 19, 2021
- Is Your Company Culture Being a Victim of COVID-19?
January 8, 2021
- It’s the Everyday Leaders Your Organization Needs
December 11, 2020
The Ministry of Health, Labor and Welfare (MHLW) on November 27 added to the NHI price list Japan’s first biosimilars of Avastin (bevacizumab), Nesp (darbepoetin alfa), and Forteo (teriparatide). The NHI prices of first biosimilars are set at 70% of…
After decades in recruitment, I say from experience that there’s a particular way to attract candidates to a given role. Do it right, and you’ll have talent chasing you. Get it wrong, and you’ll be left listening to the crickets…